Risuteganib for the treatment of DME
Peter Kaiser, MD, shares how risuteganib (Luminate, Allegro) can help with the treatment of DME when anti-VEGF treatment isn't a viable option. He presented his research in Vancouver, British Columbia, during the 2018 annual meeting of the American Society of Retina Specialists.
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Recent Videos
Related Content
